Mobile Site ›
Normal View

Test ID: PTICK
Tick-Borne Panel, Molecular Detection, PCR, Blood

Secondary ID A test code used for billing and in test definitions created prior to November 2011

83266

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Evaluation of the most common tick-borne diseases found in the United States, including human monocytic and granulocytic ehrlichiosis, and babesiosis

 

Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms

Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test IDReporting NameAvailable SeparatelyAlways Performed
PBABBabesia microti PCR, BYesYes
EHRLEhrlichia/Anaplasma PCR, BYesYes

Method Name A short description of the method used to perform the test

Real-Time Polymerase Chain Reaction (PCR)/DNA Probe Hybridization

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Tick-Borne DNA Panel, B

Aliases Lists additional common names for a test, as an aid in searching

Anaplasma phagocytophilum
Babesia gibsoni
Babesia microti
Babesiosis
E. chaffeensis
Ehrlichia chaffeensis
Ehrlichia ewingii
Ehrlichia muris-like (EML)
Ehrlichia/Anaplasma
EML (Ehrlichia muris-like)
HA (Human Anaplasmosis)
HE (Human Ehrlichiosis)
HGA (Human Granulocytic Anaplasmosis)
HGE (Human Granulocytic Ehrlichiosis)
HME (Human Monocytic Ehrlichiosis)
Human Anaplasmosis (HA)
Human Ehrlichiosis (HE)
Human Granulocytic Anaplasmosis (HGA)
Human Granulocytic Ehrlichiosis (HGE)
Human Monocytic Ehrlichiosis (HME)
Tick Borne
Tick Borne Diseases
Tick-Borne Diseases

Specimen Type Describes the specimen type needed for testing

Whole Blood EDTA

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Container/Tube: Lavender top (EDTA)

Specimen Volume: 1 mL

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

0.3 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis

Mild OK; Gross reject

Lipemia

Mild OK; Gross reject

Icterus

NA

Other

Anticoagulants other than EDTA

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
Whole Blood EDTARefrigerated (preferred)7 days
 Frozen 7 days

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

In North America, ticks are the primary vectors of infectious diseases.(1) Worldwide, ticks rank second only to mosquitoes in disease transmission. In the United States, tick-borne diseases include Lyme disease, Rocky Mountain spotted fever, human monocytic and granulocytic ehrlichiosis, babesiosis, tularemia, relapsing fever, and Colorado tick fever.

 

Symptoms of the various tick-vectored diseases range from mild to life-threatening. Early symptoms, which include fever, aches, and malaise, do not aid in distinguishing the various diseases. Because early treatment can minimize or eliminate the risk of severe disease, early detection is essential, yet patients may not have developed distinctive symptoms to help in the differential diagnosis. A tick-borne panel can assist in identifying the pathogen, allowing treatment to be initiated.

 

For information on the specific diseases, please see the individual unit codes.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Babesia microti, MOLECULAR DETECTION, PCR

Negative

 

Ehrlichia/Anaplasma, MOLECULAR DETECTION, PCR

Negative

Interpretation Provides information to assist in interpretation of the test results

See individual test IDs.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

See individual test IDs.

Supportive Data

See Individual Unit Codes

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

Mathieu ME, Wilson BB: Ticks (including tick paralysis). In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Vol. 1. Fifth edition. Edited by GL Mandell, JE Bennett, R Dolin. Philadelphia, Churchill Livingston, 2000, pp 2980-2983

Method Description Describes how the test is performed and provides a method-specific reference

See individual test IDs.

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Friday; 9 a.m.

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

Same day/1 day

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

4 days

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

See Individual Unit Codes

Performing Laboratory Location The location of the laboratory that performs the test

Rochester

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

87798 x 2

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
84319Anaplasma phagocytophilum30039-2
81147Babesia microti PCR, B21089-8
23663Ehrlichia chaffeensis27994-3
23664Ehrlichia ewingii/canis48866-8
32010Ehrlichia muris-likeIn Process